MYPS
PLAYSTUDIOS, Inc.
MYPS trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over MYPS overall, supported by stronger fundamentals and stronger valuation.
MYPS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Stable | |
| Strong |
MYPS's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MYPS PE Valuation
MYPS has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
MYPS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MYPS's losses to shrink, with revenue declining.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
MYPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.92 | -$1.02 |
| Q2 2026 | -$3.70 | -$1.30 |
| Q1 2026 | -$2.90 | -$0.50 |
| Q4 2025 | -$2.30 | -$0.10 |
| Q3 2025 | -$2.90 | -$1.00 |
| Q2 2025 | -$2.40 | -$1.00 |
| Q1 2025 | -$2.40 | -$1.10 |
| Q4 2024 | -$2.20 | -$0.70 |
MYPS lost $3.92 per share over the past year, a bigger loss than the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over MYPS on earnings quality, reporting a profit while its opponent remains loss making.
MYPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.9M | -15% |
| Q2 2026 | $55M | -7.3% |
| Q1 2026 | $58.4M | -6.9% |
| Q4 2025 | $55.4M | -18% |
| Q3 2025 | $57.6M | -19% |
| Q2 2025 | $59.3M | -18% |
| Q1 2025 | $62.7M | -19% |
| Q4 2024 | $67.8M | -12% |
MYPS's revenue has slid since its 2023 peak: $49M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -40% | -27 points |
| Q2 2026 | -17% | -12 points |
| Q1 2026 | -23% | -18 points |
| Q4 2025 | -18% | +15 points |
| Q3 2025 | -14% | -6.9 points |
| Q2 2025 | -5.9% | -0.4 points |
| Q1 2025 | -4.4% | -2.2 points |
| Q4 2024 | -33% | -30 points |
MYPS's operating margin was −40% last quarter, down 27 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over MYPS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MYPS on profitability, with a higher operating margin.
MYPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.6M | +42% |
| Q2 2026 | $5.4M | -59% |
| Q1 2026 | $3.7M | +15% |
| Q4 2025 | $3.6M | -69% |
| Q3 2025 | $5.4M | -62% |
| Q2 2025 | $13.2M | +3.4% |
| Q1 2025 | $3.2M | -10% |
| Q4 2024 | $11.5M | -19% |
MYPS still generates free cash flow, though less than at its 2020 peak: $20M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over MYPS on cash flow, with more consistent year-over-year improvement.
MYPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.6% | -718K shares |
| 1 year | -4.2% | -526K shares |
| 3 years | -20% | -2.9M shares |
| 5 years | -13% | -1.8M shares |
| Available history | -53% | -13.5M shares |
MYPS has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.2M |
| Q2 2026 | $1.6M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $49,000 |
| Q2 2025 | $1.9M |
| Q1 2025 | $1.6M |
| Q4 2024 | $2M |
MYPS spent $6M buying back its own shares over the past year, up 4.5% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
MYPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -25.2x | Net Cash |
| Q4 2025 | -7.3x | Net Cash |
| Q3 2025 | -36.8x | Net Cash |
| Q2 2025 | -14.2x | Net Cash |
| Q1 2025 | -11.0x | Net Cash |
| Q4 2024 | -8.6x | Net Cash |
| Q3 2024 | -3.2x | Net Cash |
| Q2 2024 | -3.1x | Net Cash |
MYPS has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MYPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 29.3 | Neutral |
MYPS's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MYPS PE vs Technology Sector
| Metric | MYPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MYPS has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
MYPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.45 | 8.1% above |
| 20 week MA | $5.36 | 10% below |
| 50 week MA | $5.39 | 11% below |
| 100 week MA | $9.16 | 47% below |
| 200 week MA | $19.1 | 75% below |
MYPS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 75% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
MYPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $100.5 | $100.5 | 0% |
| 2021 | $100.5 | $41.8 | -58% |
| 2022 | $41.8 | $37.7 | -9.8% |
| 2023 | $37.7 | $27.1 | -28% |
| 2024 | $27.1 | $19.1 | -30% |
| 2025 | $19.1 | $6.76 | -65% |
| 2026 YTD | $6.76 | $4.81 | -29% |
MYPS has finished every year since 2020 lower, and it's down 29% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over MYPS on returns for 2026, with the stronger performance.